On the neuropharmacology of harmane and other beta-carbolines.
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D001058:Apomorphine / Q000037:antagonists & inhibitors; D001831:Body Temperature / Q000187:drug effects; D002243:Carbolines / Q000494:pharmacology*; D002490:Central Nervous System / Q000187:drug effects*; D006247:Harmine / Q000031:analogs & derivatives / Q000494:pharmacology*; D007211:Indoles / Q000494:pharmacology*; D008297:Male; D010146:Pain / Q000503:physiopathology; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects*; D011963:Receptors, GABA-A; D011976:Receptors, Muscarinic / Q000187:drug effects; D011957:Receptors, Opioid / Q000187:drug effects; D011985:Receptors, Serotonin / Q000187:drug effects
D000470:Alkaloids; D002243:Carbolines; D007211:Indoles; D011954:Receptors, Dopamine; D011955:Receptors, Drug; D011963:Receptors, GABA-A; D011976:Receptors, Muscarinic; D011957:Receptors, Opioid; D011985:Receptors, Serotonin; D006247:Harmine; C005010:harman; D001058:Apomorphine